As of 2025-09-17, the Relative Valuation of Seres Therapeutics Inc (MCRB) is 0.57 USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.69 USD, the upside of Seres Therapeutics Inc based on Relative Valuation is -96.4%.
The range of the Relative Valuation is 0.37 - 0.87 USD.
| Range | Selected | |
| Trailing P/E multiples | 24.0x - 29.0x | 26.5x |
| Forward P/E multiples | 35.9x - 54.3x | 45.1x |
| Fair Price | 0.37 - 0.87 | 0.57 |
| Upside | -97.6% - -94.5% | -96.4% |
| Date | P/E |
| 2025-09-16 | 1,084.74 |
| 2025-09-15 | 1,009.47 |
| 2025-09-12 | 1,023.62 |
| 2025-09-11 | 1,130.42 |
| 2025-09-10 | 1,131.71 |
| 2025-09-09 | 1,199.59 |
| 2025-09-08 | 1,470.13 |
| 2025-09-05 | 1,245.59 |
| 2025-09-04 | 1,209.56 |
| 2025-09-03 | 1,190.26 |
| 2025-09-02 | 1,255.88 |
| 2025-08-29 | 1,218.57 |
| 2025-08-28 | 1,221.78 |
| 2025-08-27 | 1,214.71 |
| 2025-08-26 | 1,244.94 |
| 2025-08-25 | 1,237.22 |
| 2025-08-22 | 1,250.74 |
| 2025-08-21 | 1,178.68 |
| 2025-08-20 | 1,154.23 |
| 2025-08-19 | 1,045.50 |
| 2025-08-18 | 1,138.14 |
| 2025-08-15 | 1,073.81 |
| 2025-08-14 | 1,084.74 |
| 2025-08-13 | 1,027.48 |
| 2025-08-12 | 993.38 |
| 2025-08-11 | 934.83 |
| 2025-08-08 | 914.25 |
| 2025-08-07 | 983.73 |
| 2025-08-06 | 886.90 |
| 2025-08-05 | 918.75 |
| 2025-08-04 | 950.92 |
| 2025-08-01 | 900.09 |
| 2025-07-31 | 917.46 |
| 2025-07-30 | 926.47 |
| 2025-07-29 | 781.71 |
| 2025-07-28 | 851.84 |
| 2025-07-25 | 934.83 |
| 2025-07-24 | 862.13 |
| 2025-07-23 | 842.19 |
| 2025-07-22 | 797.15 |
| 2025-07-21 | 891.08 |
| 2025-07-18 | 905.24 |
| 2025-07-17 | 905.88 |
| 2025-07-16 | 898.81 |
| 2025-07-15 | 943.84 |
| 2025-07-14 | 955.42 |
| 2025-07-11 | 808.73 |
| 2025-07-10 | 794.58 |
| 2025-07-09 | 796.51 |
| 2025-07-08 | 746.32 |